*ST双成(002693.SZ)：公司产品注射用硼替佐米ANDA已获得美国FDA上市许可

Group 1 - The core point of the article is that *ST Shuangcheng (002693.SZ) has received FDA approval for its injectable bortezomib ANDA product [1] Group 2 - The company announced the FDA approval on its investor interaction platform [1]